March 7 (Reuters) - Novelion Therapeutics Inc NVLN.TO :
* Novelion Therapeutics - U.S. patent trial, appeal board issued written decision in inter partes review proceeding
* Novelion Therapeutics Inc - ptab affirms patentability of all claims on U.S. 7,932,268 and U.S. 8,618,135 lomitapide dosage regimen patents Source text for Eikon: ID:nGNXNQPIFa Further company coverage: NVLN.TO